Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032
- Published Date:Jan-2024
- Pages: 116
- Format: PDF
- Report ID: PM4182
- Base Year: 2023
- Historical Data: 2019 – 2022
Report Outlook
The global antidote market was valued at USD 2,117.20 million in 2023 and is expected to grow at a CAGR of 7.5% during the forecast period.
An increasing number of occupational poisonings, where exposure to harmful substances in the workplace necessitates the availability of antidotes. Additionally, the rising incidence of snake bites contributes to the demand for antidotes, as these can be life-saving interventions. Another critical driver is the escalating occurrences of drug overdoses. For instance, a study published in 2023 revealed that the U.S. witnessed approximately 106,699 fatalities due to drug overdose in 2021, underscoring the urgent need for antidotes to counteract the effects of toxic substances.
The antidote market study is a compilation of first-hand data, quantitative and qualitative assessments by industry experts, and inputs from the most relevant stakeholders in the value chain. It uses a number of analytical tools to study and assess the data of key industry players and their antidote market share. Analytical tools used to prepare the report include SWOT analysis, Porter’s Five Forces analysis, feasibility study, and investment return analysis, amongst others.
To Understand More About this Research: Request a Free Sample Report
Moreover, the prevalence of medical conditions that require antidotes has contributed to market growth. These conditions include pneumonia prophylaxis, opioid overdose, smoking cessation, toxoplasmosis, reversal of opioid sedation, trichotillomania, and sedation reversal. The demand for antidotes in these medical scenarios emphasizes the importance of having effective countermeasures available for diverse health-related emergencies.
Occupational poisoning, particularly due to pesticide exposure, is a significant concern, affecting a substantial portion of the global population. The BMC Public Health global study highlights that approximately 44% or 860 million farmers face annual poisoning incidents related to pesticides. As the incidence of occupational poisoning remains high, there is a growing need for antidotes to address and mitigate the adverse effects of such exposures.
Similarly, the rising prevalence of drug overdoses is another critical factor propelling the demand for antidotes. According to the National Safety Council, around 98,268 people in the U.S. succumbed to drug overdoses in 2021. The alarming statistics underscore the urgent need for effective antidotes to reverse the toxic effects of drug overdoses, emphasizing the crucial role that antidotes play in emergency medical situations.
Industry Dynamics
Growth Drivers
- Rising Incidence of Poisoning
There's a heightened risk of accidental poisonings with the increasing use of chemicals in industries, households, and agriculture. This drives the demand for antidotes to treat such cases promptly.
The anticipated growth in the market is further supported by increasing awareness and research initiatives led by major companies and government organizations. Notably, these efforts are directed toward fostering a better understanding of antidotes and their applications, ultimately contributing to market expansion. For instance, a virtual training workshop conducted by the World Health Organization (WHO) in May 2022. This workshop focused on coordinated antidote procurement in the Southeast Asia Region, aiming to ensure a stable and accessible supply of essential antidotes for poisoning emergencies. By organizing such workshops, the WHO and similar entities seek to educate healthcare professionals, policymakers, and stakeholders about the importance of antidotes, their proper usage, and the significance of coordinated procurement to meet emergency needs.
Report Segmentation
The market is primarily segmented based on type, route of administration, distribution channel, and region.
|
By Type |
By Route of Administration |
By Distribution Channel |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Type Analysis
- Chemical antidote segment accounted for the largest market share in 2023
The chemical antidote segment accounted for the largest share in 2023. Chemical antidotes play a crucial role in providing targeted and swift treatment for specific toxins, ensuring efficacy while minimizing complications. Trained professionals administer these antidotes, enabling immediate action to reduce long-term health effects and deliver predictable emergency outcomes. The precise dosing and customization features of chemical antidotes enhance their therapeutic value, making them indispensable in specialty care settings for addressing poisoning and toxic exposures.
The pharmacological segment will grow rapidly over the anticipated period. Many existing antidotes only partially counteract the effects of toxins, targeting the body's tissues and inducing symptoms that are opposite to those caused by poisoning. In comparison to physical and chemical antidotes, pharmacological antidotes pose no harm. Examples of pharmacological antidotes include cyanide and amyl nitrate, barbiturates, picrotoxin, or amphetamine. For instance, the pharmacological antidote ACHE inhibitor-morphine facilitates the rapid and complete elimination of toxins by restoring normal function.
By Route of Administration Analysis
- Injectables segment held a significant market share in 2023
In 2023, the injectables sector dominated the market landscape. Notably, antidote injections have earned a reputation for their ability to swiftly and precisely counteract the effects of toxins or medications. These injections are invaluable in emergency scenarios, effectively mitigating the harmful impacts of various toxic substances. They are specifically tailored to neutralize toxins, ensuring that treatments are both accurate and efficient.
On the other hand, the oral sector is poised for significant growth in the coming years. The rising preference for oral antidote administration can be attributed to its widespread acceptance among patients. Oral antidotes present numerous benefits, such as minimizing discomfort, since they negate the necessity for injections. This makes them a more favorable option for many individuals. Additionally, in certain situations, patients can self-administer oral antidotes, a vital feature especially when immediate intervention is required before professional medical assistance can be obtained.
By Distribution Channel Analysis
- Hospital pharmacies segment held a significant market share in 2023
In 2023, the hospital pharmacy sector emerged as a dominant force in the market, capturing a significant share. This ascendancy can be credited to a range of factors, including the enhanced availability of antidote treatments and medicines dispensed by these pharmacies. Patients have found it increasingly convenient to procure their prescribed drugs and associated items from hospital pharmacies, fueling the demand for such services. Furthermore, the increased involvement of hospital pharmacies in patient education and advisory roles in antidote treatment plans is poised to be a pivotal driver for the sector's growth.
On the other hand, the online pharmacy sector is projected to witness a remarkable growth trajectory in the upcoming forecast period. The allure of convenience, adaptability, and simplicity in purchasing medications online has been instrumental in propelling this segment forward. Additionally, the attractive discounts extended by online pharmaceutical outlets act as a potent motivator for consumers to opt for digital platforms when sourcing their medicinal needs.
Regional Insights
- North America dominated the global market in 2023
North America dominated the global market. The region has seen a rise in the burden of poisoning, as indicated by data from the National Capital Poison Center (NCPC), estimating that one poison exposure case is reported every 15 seconds in the U.S. poison control centers. The substantial presence of major operating players in the antidote market within the region is expected to contribute to the increased availability of antidotes in the region. Moreover, the growth is further driven by the increasing healthcare spending and improved medical facilities in the region.
The Asia Pacific will grow at a substantial pace during the forecast period. The high incidence of insecticide poisoning in the region has further fueled the demand for antidotes. For instance, a 2023 research article from the National Center for Biotechnology Information (NCBI) reported approximately 76,000 organophosphate poisoning cases in India annually. The cost of conducting clinical trials in developing economies is lower compared to developed economies. This factor encourages pharmaceutical companies to invest in research activities in these regions. Additionally, the growing disposable income in developing economies like India and China has increased the affordability of antidote medications.
Key Market Players & Competitive Insights
Companies are implementing strategic initiatives to enhance their market position, including collaborations on product development, expanding their geographic presence, and entering strategic agreements to diversify their product portfolios. These measures are aimed at maximizing market share and ensuring a more comprehensive and competitive offering within the industry.
Some of the major players operating in the global market include:
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Dr. Reddy’s Laboratories Ltd
- Mylan N.V.
- Fresenius Kabi AG
- Zydus Lifesciences Ltd.
- Endo International plc
- Novartis AG
- Baxter International, Inc.
- Emergent BioSolutions Inc.
Recent Developments
- In March 2023, EMERGENT received approval from the U.S. FDA for Narcan, making it the first over-the-counter nasal spray approved for the treatment of opioid overdose.
Antidote Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 2,271.33 million |
|
Revenue Forecast in 2032 |
USD 4,052.36 million |
|
CAGR |
7.5% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2032 |
|
Segments Covered |
By Services, By End Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
Navigate through the intricacies of the 2024 antidote market with precision, thanks to the comprehensive statistics on market share, size, and revenue growth rate assembled by Polaris Market Research Industry Reports. This thorough analysis not only provides a glimpse into the historical context but also extends its reach with a market forecast outlook until 2032. Immerse yourself in the richness of this industry analysis by securing a complimentary PDF download of the sample report.
FAQ's
The global antidote market size is expected to reach USD 4,052.36 Million by 2032
Key players in the market are Pfizer, Hikma Pharmaceuticals, Mylan, Fresenius, Zydus Lifesciences
North America contribute notably towards the global Antidote Market
The global antidote market is expected to grow at a CAGR of 7.5% during the forecast period.
The Antidote Market report covering key segments are type, route of administration, distribution channel, and region.
